Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49.035
Filtrar
1.
Recurso de Internet en Portugués | LIS - Localizador de Información en Salud | ID: lis-48177

RESUMEN

O pacto foi lançado nesta quarta-feira (14) na Cúpula Global da Diabetes, que é copatrocinada pela OMS e pelo governo do Canadá com o apoio da Universidade de Toronto. Durante o evento, o presidente do Quênia se juntou aos primeiros-ministros de Fiji, Noruega e Cingapura; o embaixador global da OMS para Doenças e Lesões Não Transmissíveis, Michael R. Bloomberg; e ministros da saúde de vários países, bem como especialistas em diabetes e pessoas que vivem com doença para destacar as maneiras pelas quais apoiarão este novo esforço colaborativo.


Asunto(s)
Diabetes Mellitus/prevención & control , Organización Mundial de la Salud , Cooperación Internacional , Prevención de Enfermedades
2.
Recurso de Internet en Portugués | LIS - Localizador de Información en Salud | ID: lis-48162

RESUMEN

O ministro da Saúde, Marcelo Queiroga, debateu neste sábado (3/4) com a Organização Mundial da Saúde (OMS) e a Organização Pan-Americana da Saúde (OPAS) uma colaboração técnica para ampliar a capacidade de produção nacional de vacinas no Brasil.


Asunto(s)
Vacunas/provisión & distribución , Organización Mundial de la Salud , Organización Panamericana de la Salud , Producción de Productos
3.
Washington, D.C; PAHO; 2021-04-27.
en Inglés | PAHO-IRIS | ID: phr-34049

RESUMEN

This entry contains the Status Report of WHO Collaborating Centres in the Americas by Country and a new document with information of Collaborating Centres by Outcome of the Strategic Plan of the Pan American Health Organization 2020‑2025.


Asunto(s)
Cooperación Internacional , Américas , Cooperación Técnica , Organización Mundial de la Salud
4.
Artículo en Inglés | MEDLINE | ID: mdl-33802347

RESUMEN

Anthropogenic climate change is adversely impacting people and contributing to suffering and increased costs from climate-related diseases and injuries. In responding to this urgent and growing public health crisis, mitigation strategies are in place to reduce future greenhouse gas emissions (GHGE) while adaptation strategies exist to reduce and/or alleviate the adverse effects of climate change by increasing systems' resilience to future impacts. While these strategies have numerous positive benefits on climate change itself, they also often have other positive externalities or health co-benefits. This knowledge can be harnessed to promote and improve global public health, particularly for the most vulnerable populations. Previous conceptual models in mitigation and adaptation studies such as the shared socioeconomic pathways (SSPs) considered health in the thinking, but health outcomes were not their primary intention. Additionally, existing guidance documents such as the World Health Organization (WHO) Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities is designed primarily for public health professionals or healthcare managers in hospital settings with a primary focus on resilience. However, a detailed cross sectoral and multidisciplinary conceptual framework, which links mitigation and adaptation strategies with health outcomes as a primary end point, has not yet been developed to guide research in this area. In this paper, we briefly summarize the burden of climate change on global public health, describe important mitigation and adaptation strategies, and present key health benefits by giving context specific examples from high, middle, and low-income settings. We then provide a conceptual framework to inform future global public health research and preparedness across sectors and disciplines and outline key stakeholders recommendations in promoting climate resilient systems and advancing health equity.


Asunto(s)
Cambio Climático , Gases de Efecto Invernadero , Salud Global , Humanos , Salud Pública , Organización Mundial de la Salud
5.
Artículo en Inglés | MEDLINE | ID: mdl-33808750

RESUMEN

Background: There are approximately two billion workers in the informal economy globally. Compared to workers in the formal economy, these workers are often marginalised with minimal or no benefits from occupational health and safety regulations, labour laws, social protection and/or health care. Thus, informal economy workers may have higher occupational health risks compared to their formal counterparts. Our objective was to systematically review and meta-analyse evidence on relative differences (or inequalities) in health services use and health outcomes among informal economy workers, compared with formal economy workers. Methods: We searched PubMed and EMBASE in March 2020 for studies published in 1999-2020. The eligible population was informal economy workers. The comparator was formal economy workers. The eligible outcomes were general and occupational health services use, fatal and non-fatal occupational injuries, HIV, tuberculosis, musculoskeletal disorders, depression, noise-induced hearing loss and respiratory infections. Two authors independently screened records, extracted data, assessed risk of bias with RoB-SPEO, and assessed quality of evidence with GRADE. Inverse variance meta-analyses were conducted with random effects. Results: Twelve studies with 1,637,297 participants from seven countries in four WHO regions (Africa, Americas, Eastern Mediterranean and Western Pacific) were included. Compared with formal economy workers, informal economy workers were found to be less likely to use any health services (odds ratio 0.89, 95% confidence interval 0.85-0.94, four studies, 195,667 participants, I2 89%, low quality of evidence) and more likely to have depression (odds ratio 5.02, 95% confidence interval 2.72-9.27, three studies, 26,260 participants, I2 87%, low quality of evidence). We are very uncertain about the other outcomes (very-low quality of evidence). Conclusion: Informal economy workers may be less likely than formal economy workers to use any health services and more likely to have depression. The evidence is uncertain for relative differences in the other eligible outcomes. Further research is warranted to strengthen the current body of evidence and needed to improve population health and reduce health inequalities among workers.


Asunto(s)
Enfermedades Profesionales , Exposición Profesional , África , Américas , Costo de Enfermedad , Servicios de Salud , Humanos , Enfermedades Profesionales/epidemiología , Exposición Profesional/análisis , Evaluación de Resultado en la Atención de Salud , Organización Mundial de la Salud
6.
J Infect Dev Ctries ; 15(3): 342-349, 2021 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-33839707

RESUMEN

INTRODUCTION: Our study aims to assess the prevalence of COVID-19 in the Middle East and North Africa (MENA) region. It aims also to examine the various factors that have led to the unequal distribution of the confirmed cases among the different MENA countries. METHODOLOGY: Data was retrieved from the World Health Organization situation reports issued between January 29 and June 5, 2020. It included the numbers of cumulative cases, new cases, and cumulative deaths reported by MENA countries. Similarly, we searched for relevant articles in PubMed and Medline. RESULTS: A total of 481,347 cases and 11,851 deaths occurred in the MENA region, accounting for 7.37% and 3.06% of the global cases and deaths respectively. Iran had the highest number of cases and deaths accounting for 34.1% and 68.1% of the MENA cases and deaths respectively. Together the Gulf Cooperation Council (GCC) countries accounted for 52.2% and 10.6% of MENA cases and deaths respectively. Egypt had the highest number of confirmed cases and deaths among the African countries of the region. Syria, Libya and Yemen (countries at war) had the lowest numbers of reported cases. The MENA region overall case fatality rate (CFR) was estimated at 2.46%. The highest CFR (22.75%) occurred in Yemen, and the lowest (0.07%) in Qatar. CONCLUSIONS: The unequal distribution of wealth among the MENA countries, the lack of sociopolitical stability, and the high number of undetected and underreported cases in some of them have resulted in varied incidences of COVID-19 related morbidity and mortality.


Asunto(s)
/epidemiología , Organización Mundial de la Salud , África del Norte/epidemiología , Humanos , Incidencia , Medio Oriente/epidemiología , Política , Prevalencia , Factores Socioeconómicos
11.
J Environ Pathol Toxicol Oncol ; 40(2): 89-98, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33822520

RESUMEN

AIM: In our study, a new grading model (e-GM) including nuclear membrane irregularity highlighted by emerin expression was proposed for renal cell carcinomas (RCC). It was aimed to investigate the relationship of this model with WHO/ISUP grading system, histopathological features, and prognosis. METHODS AND RESULTS: 86 RCC cases were included in the study. The mean age of the patients was 59.65, and the mean tumor size was 6.36 cm. According to pTNM staging, 45 of the cases were stage 1, 11 were stage 2, 26 were stage 3, and 4 were stage 4. According to e-GM grading, advanced tumor grade was found to be associated with perirenal tissue extension, necrosis, lymphovascular invasion, distant metastasis, advanced pT and TNM stage. Nuclear membrane irregularity caused an increase in tumor grade in 17 wi-GS grade 1 cases, 14 WHO/ISUP grading system (wi-GS) grade 2 cases, and 1 wi-GS grade 3 case. In the stepwise statistical analysis, it was determined that the most important prognostic factor was the TNM stage, followed by age and tumor size. CONCLUSIONS: Statistical analyses showed that nuclear membrane irregularity should be a criterion for classification according to e-GM in wi-grade 2 cases, but not necessarily in wi-grade 1 cases. Nuclear membrane irregularity was a prominent feature at high tumor grades, and its expression in RCCs suggests that it may be a target for tumor-specific treatments.


Asunto(s)
Carcinoma de Células Renales/metabolismo , Carcinoma de Células Renales/patología , Neoplasias Renales/metabolismo , Neoplasias Renales/patología , Proteínas de la Membrana/metabolismo , Proteínas Nucleares/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Renales/mortalidad , Femenino , Humanos , Inmunohistoquímica , Neoplasias Renales/mortalidad , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Análisis de Supervivencia , Carga Tumoral , Organización Mundial de la Salud
12.
Artículo en Inglés | MEDLINE | ID: mdl-33805338

RESUMEN

Knowledge of physical activity (PA) can be considered a predictor of public health for society. Thus, this study aims to show content validity of the "Knowledge Questionnaire on World Health Organization (WHO) Recommendations on PA and Health" (CUAFYS-A) and reference values on adults' knowledge of the WHO recommendations on PA. This is a quantitative, non-experimental, descriptive, and cross-sectional study, in which 579 adults completed an online questionnaire with demographic data. The questionnaire was made up of 9 items to measure PA related to knowledge. For the elaboration of the items of the questionnaire a disciplinary team formed it and for the analysis of results, a descriptive analysis of these was applied. Then an inferential analysis was performed, content validity, construct validity, and reliability were analyzed. The CUAFYS-A after its content analysis, obtained appropriate results in terms of pertinence and relevance; additionally, it showed Cronbach's alpha coefficient of 0.62. Thereby, it was concluded the CUAFYS-A questionnaire proved to be a valid and reliable instrument to show reference values and to evaluate the knowledge of adults of PA and health according to the WHO recommendations.


Asunto(s)
Ejercicio Físico , Colombia , Estudios Transversales , Reproducibilidad de los Resultados , Encuestas y Cuestionarios , Organización Mundial de la Salud
14.
JMIR Public Health Surveill ; 7(4): e28945, 2021 04 21.
Artículo en Inglés | MEDLINE | ID: mdl-33881404

RESUMEN

The World Health Organization (WHO) launched the first web-based learning course on COVID-19 on January 26, 2020, four days before the director general of the WHO declared a public health emergency of international concern. The WHO is expanding access to web-based learning for COVID-19 through its open-learning platform for health emergencies, OpenWHO. Throughout the pandemic, OpenWHO has continued to publish learning offerings based on the WHO's emerging evidence-based knowledge for managing the COVID-19 pandemic. This study presents the various findings derived from the analysis of the performance of the OpenWHO platform during the pandemic, along with the core benefits of massive web-based learning formats.


Asunto(s)
/prevención & control , Educación a Distancia , Pandemias/prevención & control , /epidemiología , Guías como Asunto , Humanos , Organización Mundial de la Salud
18.
Int Nurs Rev ; 68(1): 9-11, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33891771

RESUMEN

Preparing the world to manage future pandemics must take priority. It is clear that we were not prepared for the COVID-19 pandemic which continues to cause great suffering around the world. Nurses and other health professionals everywhere must be involved in health policy planning and implementation of public health measures to combat this and future pandemics. Such preparation needs community policy involvement at grassroots levels and needs to be collaboratively instigated at international levels. The death so far of over 2000 nurses is unacceptable in this pandemic, and we need to better protect and sustain the workforce. The International Council of Nurses has been instrumental in data gathering of nurses' experiences during COVID-19. Key points from analysis of this data have been included in Second Progress Report of the World Health Organization's Independent Panel for Pandemic Preparedness and Response. This paper summarises the key messages from this report, as well as the nursing shortage. The International Council of Nurses resounds the call for massive investment in nursing education, leadership and jobs, as well as protection for our nurses on the frontlines of the pandemic.


Asunto(s)
/epidemiología , Rol de la Enfermera , Planificación en Desastres , Educación en Enfermería , Predicción , Humanos , Control de Infecciones/normas , Liderazgo , Pandemias , Sociedades de Enfermería , Organización Mundial de la Salud
20.
Epidemiol Mikrobiol Imunol ; 70(1): 18-25, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33853334

RESUMEN

OBJECTIVES: Long-term monitoring of the mutual effects of chronic viral hepatitis C (VHC) treatment and tailored addiction treatment. In 2016, the World Health Organization (WHO) published an action plan to eliminate viral hepatitis C globally by 2030. People who inject drugs (PWID) are a key population that needs increased attention and care. Two decades before the announcement of the WHO plan for the global elimination of HCV (hepatitis C virus), the Remedis Medical Facility, where the study was conducted, established a “Comprehensive Care Program for patients with substance use disorders and addictive behaviour”. METHODS: We evaluated all patients who were in the methadone program as of 1 March 2020, regardless of OST duration, OST dosage, age or gender. Their epidemiological and demographic data obtained during a structured clinical interview and laboratory test results were analysed. RESULTS: Of 24 patients on methadone substitution therapy, 12 (50%) were anti-HCV negative before starting OST. None of them became newly infected with hepatitis C virus (HCV) during OST. The remaining 12 of the study patients were anti-HCV positive. Ten of them have already undergone successful treatment for viral hepatitis. Two patients were re-infected with HCV. CONCLUSION: The presented work confirms the high efficacy of chronic VHC treatment among PWID in inducing suitable conditions. We consider combination of HCV infection treatment and targeted tailored addiction treatment as a starting point for achieving control over the HCV epidemic in the Czech Republic, with a possible positive impact on other blood-borne infections related to risky behaviour.


Asunto(s)
Hepatitis C , Preparaciones Farmacéuticas , Abuso de Sustancias por Vía Intravenosa , Antivirales/uso terapéutico , República Checa , Hepatitis C/tratamiento farmacológico , Hepatitis C/epidemiología , Humanos , Metadona/uso terapéutico , Tratamiento de Sustitución de Opiáceos , Abuso de Sustancias por Vía Intravenosa/complicaciones , Abuso de Sustancias por Vía Intravenosa/epidemiología , Organización Mundial de la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...